MediterrAsian diet products that could raise HDL-cholesterol: A systematic review

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Rondanelli, Mariangela ^a   Giacosa, Attilio ^b   Morazzoni, Paolo ^c   Guido, Davide ^a   Grassi, Mario ^a   Morandi, Gabriella ^a   Bologna, Chiara ^a   Riva, Antonella ^c   Allegrini, Pietro ^c   Perna, Simone ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Policlinico di Monza   (Italy)

^c INDENA S P A   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BERGAMOT OIL; CHOLESTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; VIRGIN OLIVE OIL; BIOLOGICAL PRODUCT; OLIVE OIL; VEGETABLE OIL;

ARTICHOKE; ASIAN; DIET SUPPLEMENTATION; DYSLIPIDEMIA; HEART INFARCTION; HUMAN; MEDITERRANEAN DIET; REVIEW; SYSTEMATIC REVIEW; BLOOD; CARDIOVASCULAR DISEASES; DIET THERAPY;

BIOLOGICAL PRODUCTS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CYNARA SCOLYMUS; DIET, MEDITERRANEAN; HUMANS; OLIVE OIL; PLANT OILS;

EID: 84997514523     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/2025687     Document Type: Review

References (65)

1. C. J. L. Murray and A. D. Lopez, "Global mortality, disability, and the contribution of risk factors: global burden of disease study," The Lancet, vol. 349, no. 9063, pp. 1436-1442, 1997.
2. K. S. Jain, M. K. Kathiravan, R. S. Somani, and C. J. Shishoo, "The biology and chemistry of hyperlipidemia," Bioorganic and Medicinal Chemistry, vol. 15, no. 14, pp. 4674-4699, 2007.
3. G. De Backer, E. Ambrosioni, K. Borch-Johnsen et al., "European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts)," European Journal of Cardiovascular Prevention and Rehabilitation, vol. 10, no. 4, pp. S1-S10, 2003.
4. D. J. Gordon, J. L. Probstfield, R. J. Garrison et al., "Highdensity lipoprotein cholesterol and cardiovascular disease. Four prospective American studies," Circulation, vol. 79, no. 1, pp. 8-15, 1989.
5. A. M. Gotto, S. J. Boccuzzi, J. R. Cook et al., "Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group," American Journal of Cardiology, vol. 86, pp. 1176-1181, 2000.
6. J. Shepherd, S. M. Cobbe, I. Ford et al., "Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia," The New England Journal of Medicine, vol. 333, no. 20, pp. 1301-1307, 1995.
7. F. M. Sacks, M. A. Pfeffer, L. A. Moye et al., "The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators,"The New England Journal of Medicine, vol. 335, no. 14, pp. 1001-1009, 1996.
8. Scandinavian Simvastatin Survival Study Group, "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)," The Lancet, vol. 344, no. 8934, pp. 1383-1389, 1994.
9. M. J. Chapman, "Are the effects of statins on HDL-cholesterol clinically relevant?" European Heart Journal Supplements, vol. 6, pp. C58-C63, 2004.
10. R. B. Kelly, "Diet and exercise in the management of hyperlipidemia," American Family Physician, vol. 81, no. 9, pp. 1097-1102, 2010.
11. W. C. Willett, F. Sacks, A. Trichopoulou et al., "Mediterranean diet pyramid: a culturalmodel for healthy eating,"TheAmerican Journal of Clinical Nutrition, vol. 61, no. 6, supplement, pp. 1402S-1406S, 1995.
12. T.A.Nicklas, C. E.O'Neil, andV. L. Fulgoni, "Rice consumption is associated with better nutrient intake and diet quality in adults: National Health and Nutrition Examination survey (NHANES) 2005-2010," Food and Nutrition Sciences, vol. 5, pp. 525-532, 2014.
13. K. Pallauf, K. Giller, P. Huebbe, and G. Rimbach, "Nutrition and healthy ageing: calorie restriction or polyphenolrich 'MediterrAsian' diet?" Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 707421, 14 pages, 2013.
14. E. A. Brinton, "Effects of ethanol intake on lipoproteins," Current Atherosclerosis Reports, vol. 14, no. 2, pp. 108-114, 2012.
15. J. M. Miranda, X. Anton, C. Redondo-Valbuena et al., "Egg and egg-derived foods: effects on human health and use as functional foods," Nutrients, vol. 7, no. 1, pp. 706-729, 2015.
16. C. J. Andersen, C. N. Blesso, J. Lee et al., "Egg consumption modulates HDL lipid composition and increases the cholesterol-accepting capacity of serum in metabolic syndrome," Lipids, vol. 48, no. 6, pp. 557-567, 2013.
17. M. Egger, K. Dickersin, and G. D. Smith, "Problems and limitations in conducting systematic reviews," in Systematic Reviews in Health Care:Meta-Analysis in Context, M. Egger, G. D. Smith, andD.G.Altman, Eds., BMJ Books, London,UK, 2nd edition, 2001.
18. National Library ofMedicine, Bethesda,Md, USA, http://www .pubmed.com.
19. http://www.scopus.com/.
20. http://thomsonreuters.com/en.html.
21. http://www.scholar.google.com.
22. P. M. Moriarty, E. M. Roth, A. Karns et al., "Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study," Journal of Clinical Lipidology, vol. 8, no. 6, pp. 568-575, 2014.
23. C.-Y. Lee,M.-S. Jan, M.-C. Yu, C.-C. Lin, J. C.-C.Wei, and H.-C. Shih, "Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice," Forschende Komplementarmedizin, vol. 20, no. 3, pp. 197-203, 2013.
24. S. C. Halbert, B. French, R. Y. Gordon et al., "Tolerability of red yeast rice (2,400mg twice daily) versus Pravastatin (20mg twice daily) in patients with previous statin intolerance," American Journal of Cardiology, vol. 105, no. 2, pp. 198-204, 2010.
25. D. J. Becker, R. Y. Gordon, S. C. Halbert, B. French, P. B. Morris, and D. J. Rader, "Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial," Annals of Internal Medicine, vol. 150, no. 12, pp. 830-839, 2009.
26. C. Stefanutti, F.Mazza, A. Vivenzio et al., "Combined treatment with Dif1stat and diet reduce plasma lipid indicators of moderate hypercholesterolemia more effectively than diet alone: a randomized trial in parallel groups," Lipids, vol. 44, no. 12, pp. 1141-1148, 2009.
27. D. Heber, I. Yip, J. M. Ashley, D. A. Elashoff, R. M. Elashoff, and V. L. W. Go, "Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement," American Journal of Clinical Nutrition, vol. 69, no. 2, pp. 231-236, 1999.
28. Z. Lu, W. Kou, B. Du et al., "Effect of xuezhikang, an extract from red yeast chinese rice, on coronary events in a chinese population with previous myocardial infarction," American Journal of Cardiology, vol. 101, no. 12, pp. 1689-1693, 2008.
29. Centre for Evidence-Based Medicine. Levels of Evidence. New Levels of Evidence Table, http://www.cebm.net/index .aspx?o=5653.
30. K. C. Maki, A. L. Lawless, K. M. Kelley, V. N. Kaden, C. J. Geiger, and M. R. Dicklin, "Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: results from a randomized controlled feeding trial," Journal of Clinical Lipidology, vol. 9, no. 1, pp. 49-57, 2015.
31. K. C. Maki, M. E. Van Elswyk, D. McCarthy et al., "Lipid responses to a dietary docosahexaenoic acid supplement inmen and women with below average levels of high density lipoprotein cholesterol," Journal of the American College of Nutrition, vol. 24, no. 3, pp. 189-199, 2005.
32. J.Geppert,V.Kraft,H.Demmelmair, and B.Koletzko, "Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial," British Journal of Nutrition, vol. 95, no. 4, pp. 779-786, 2006.
33. G. S. Rambjør, A. I. Walen, S. L. Windsor, and W. S. Harris, "Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans," Lipids, vol. 31, no. 1, pp. S45-S49, 1996.
34. A. Hernaez, S. Fernandez-Castillejo, M. Farras et al., "Olive oil polyphenols enhance high-density lipoprotein function in humans: a randomized controlled trial,"Arteriosclerosis,Thrombosis, and Vascular Biology, vol. 34, no. 9, pp. 2115-2119, 2014.
35. J. M. Gaullier, J. Halse, K. Høye et al., "Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans,"The American Journal of Clinical Nutrition, vol. 79, no. 6, pp. 1118-1125, 2004.
36. M.N.Vissers,P.L.Zock, S. A.Wiseman, S.Meyboom, andM. B. Katan, "Original communications-effect of phenol-rich extra virgin olive oil on markers of oxidation in healthy volunteers," European Journal of ClinicalNutrition, vol. 55,pp. 334-341, 2001.
37. J. Marrugat, M. I. Covas, M. Fito et al., "Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation," European Journal of Nutrition, vol. 43,no. 3, pp. 140-147, 2004.
38. M.-I. Covas, K. Nyyssonen, H. E. Poulsen et al., "The effect of polyphenols in olive oil on heart disease risk factors: A randomized trial," Annals of Internal Medicine, vol. 145, no. 5, pp. 333-341, 2006.
39. M.-J. Oliveras-Lopez, J. J. M. Molina, M. V. Mir, E. F. Rey, F. Martin, and H. L.-G. de la Serrana, "Extra virgin olive oil (EVOO) consumption and antioxidant status in healthy institutionalized elderly humans," Archives of Gerontology and Geriatrics, vol. 57, no. 2, pp. 234-242, 2013.
40. M.-J. Oliveras-Lopez, M. Innocenti, F. Martin Bermudo, H. Lopez-Garca de la Serrana, and N. Mulinacci, "Effect of extra virgin olive oil on glycaemia in healthy young subjects," European Journal of Lipid Science and Technology, vol. 114, no. 9, pp. 999-1006, 2012.
41. O. Helal, H. Berrougui, S. Loued, and A. Khalil, "Extra-virgin olive oil consumption improves the capacity of HDL tomediate cholesterol efflux and increases ABCA1 and ABCG1 expression in human macrophages," British Journal of Nutrition, vol. 109, no. 10, pp. 1844-1855, 2013.
42. J. A. Lovegrove, S. S. Lovegrove, S.V. Lesauvage et al., "Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians," The American Journal of Clinical Nutrition, vol. 79, no. 6, pp. 974-982, 2004.
43. T.Weinbrenner, M. Fito, R.De La Torre et al., "Olive oils high in phenolic compoundsmodulate oxidative/antioxidative status in men," Journal of Nutrition, vol. 134, no. 9, pp. 2314-2321, 2004.
44. A. Derouiche, M. Cherki, A. Drissi et al., "Nutritional intervention study with argan oil in man: effects on lipids and apolipoproteins," Annals of Nutrition and Metabolism, vol. 49, no. 3, pp. 196-201, 2005.
45. M. Gliozzi, R. Walker, S. Muscoli et al., "Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDLcholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia," International Journal of Cardiology, vol. 170, no. 2, pp. 140-145, 2013.
46. V. Mollace, I. Sacco, E. Janda et al., "Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies," Fitoterapia, vol. 82, no. 3, pp. 309-316, 2011.
47. M. Rondanelli, A. Opizzi, M. Faliva et al., "Metabolic management in overweight subjects with naive impaired fasting glycaemia by means of a highly standardized extract from cynara scolymus: a double-blind, placebo-controlled, randomized clinical trial," Phytotherapy Research, vol. 28, no. 1, pp. 33-41, 2014.
48. R. Bundy, A. F. Walker, R. W. Middleton, C. Wallis, and H. C. R. Simpson, "Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial," Phytomedicine, vol. 15, no. 9, pp. 668-675, 2008.
49. P. Nazni, T. Poongodi Vijayakumar, P. Alagianambi, and M. Amirthaveni, "Hypoglycemic and hypolipidemic effect of Cynara scolymus among selected type 2 diabetic individuals," Pakistan Journal of Nutrition, vol. 5, no. 2, pp. 147-151, 2006.
50. M. Rondanelli, A. Giacosa, A. Opizzi et al., "Beneficial effects of artichoke leaf extract supplementation on increasing HDLcholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial," International Journal of Food Sciences and Nutrition, vol. 64, no. 1, pp. 7-15, 2013.
51. W. Englisch, C. Beckers, M. Unkauf, M. Ruepp, and V. Zinserling, "Efficacy of artichoke dry extract in patients with hyperlipoproteinemia," Arzneimittel-Forschung/Drug Research, vol. 50, no. 3, pp. 260-265, 2000.
52. M. B. Katan, P. L. Zock, and R. P. Mensink, "Effects of fats and fatty acids on blood lipids in humans: an overview," American Journal of Clinical Nutrition, vol. 60, supplement 6, pp. 1017S-1022S, 1994.
53. M. B. Katan, P. L. Zock, and R. P.Mensink, "Dietary oils, serum lipoproteins, and coronary heart disease," The American Journal of Clinical Nutrition, vol. 61,no. 6, supplement, pp. 1368S-1373S, 1995.
54. S. Granados-Principal, J. L. Quiles, C. L. Ramirez-Tortosa, P. Sanchez-Rovira, and M. C. Ramirez-Tortosa, "Hydroxytyrosol: fromlaboratory investigations to future clinical trials," Nutrition Reviews, vol. 68, no. 4, pp. 191-206, 2010.
55. M. Gonzalez-Santiago, E. Martin-Bautista, J. J. Carrero et al., "One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development," Atherosclerosis, vol. 188, no. 1, pp. 35-42, 2006.
56. I. Fki, Z. Sahnoun, and S. Sayadi, "Hypocholesterolemic effects of phenolic extracts and purified hydroxytyrosol recovered from olive mill wastewater in rats fed a cholesterol-rich diet," Journal of Agricultural and Food Chemistry, vol. 55, no. 3, pp. 624-631, 2007.
57. H. Jemai, I. Fki, M. Bouaziz et al., "Lipid-lowering and antioxidant effects of hydroxytyrosol and its triacetylated derivative recovered from olive tree leaves in cholesterol-fed rats," Journal of Agricultural and Food Chemistry, vol. 56, no. 8, pp. 2630-2636, 2008.
58. H. Jemai, M. Bouaziz, and S. Sayadi, "Phenolic composition, sugar contents and antioxidant activity of Tunisian sweet olive cultivar with regard to fruit ripening," Journal of Agricultural and Food Chemistry, vol. 57, no. 7, pp. 2961-2968, 2009.
59. J. E. Brown and C. A. Rice-Evans, "Luteolin-rich artichoke extract protects lowdensity lipoprotein fromoxidation in vitro," Free Radical Research, vol. 29, no. 3, pp. 247-255, 1998.
60. R. Gebhardt, "Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreatment," Phytotherapy Research, vol. 16, no. 4, pp. 368-372, 2002.
61. B.Wider, M. H. Pittler, J. Thompson-Coon, and E. Ernst, "Artichoke leaf extract for treating hypercholesterolaemia," Cochrane Database of Systematic Reviews, no. 4, Article ID CD003335, 2009.
62. C. Gouedard, R. Barouki, and Y. Morel, "Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism," Molecular and Cellular Biology, vol. 24, no. 12, pp. 5209-5222, 2004.
63. A. Gugliucci and D. H. M. Bastos, "Chlorogenic acid protects paraoxonase 1 activity in high density lipoprotein from inactivation caused by physiological concentrations of hypochlorite," Fitoterapia, vol. 80, no. 2, pp. 138-142, 2009.
64. M. S. van der Gaag, A. van Tol, L. M. Scheek et al., "Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men," Atherosclerosis, vol. 147, no. 2, pp. 405-410, 1999.
65. A. Sierksma, M. S. van der Gaag, A. van Tol, R. W. James, and H. F. J.Hendriks, "Kinetics ofHDL cholesterol and paraoxonase activity in moderate alcohol consumers," Alcoholism: Clinical and Experimental Research, vol. 26, no. 9, pp. 1430-1435, 2002.